India's TB Burden and Treatment Challenges
India accounts for over 25% of the global TB burden, with 2.8 million new cases annually.
More than half of TB patients in India seek treatment in private hospitals, facing challenges related to affordability and care quality.
Public hospitals offer free treatment but may lack a welcoming environment and optimal care, while private hospitals provide better comfort but may not always follow standardized treatment protocols.
Public-Private Care Collaboration
Government hospitals provide standard care and contact tracing, but patients may feel the treatment quality is compromised.
Private hospitals offer a better environment but may lack compliance and proper follow-up for TB patients.
A partnership between public and private sectors can offer patients more treatment options and better outcomes, while ensuring adherence to treatment protocols and follow-up.
Medicine Availability and Adherence
Certain anti-TB medicines, especially for drug-resistant TB, are only available in government hospitals to prevent misuse.
Public health policies require patients with drug-resistant TB to be admitted for two weeks, which can be inconvenient but ensures better follow-up and treatment.
A collaboration between public and private sectors, with flexible care pathways, could provide patients with more access to necessary medicines and improve treatment adherence.
The Way Forward
A better system for smooth transition of patient care between public and private sectors is essential, addressing issues like accountability and unregistered practitioners.
TB diagnostic testing and treatment protocols should be standardized, with regulations on drug supply and adherence.
Monitoring systems for laboratories, pharmacies, and drug sales, as well as expert committees, will ensure better coordination and follow-up.
Re-imagining public-private partnerships can improve TB control and care delivery.
COMMENTS